Generic Price-Fixing: Sandoz Employee Notebook Provides Evidence For AGs' Third Suit
Executive Summary
Complaint names 26 generic dermatologic drug manufacturers and 10 individual executives as defendants, alleging they engaged in a widespread conspiracy to artificially inflate and manipulate prices. State attorneys general say that structural and personnel changes at the companies fostered and facilitated collusion.